Your browser doesn't support javascript.
loading
Multi-system involvement-including purpura fulminans-as an adverse effects of immune checkpoint inhibitor therapy for clear cell renal cell carcinoma.
Wirbel, Chloé; Breton, Anne Laure; Donzier, Léa; Tartas, Sophie; Curings, Pierre; Pariset, Caroline; Berthoux, Emilie.
Affiliation
  • Wirbel C; Department of Dermatology, Hospices Civils de Lyon, Oullins-Pierre-Bénite, Lyon, France. Electronic address: chloewirbel@gmail.com.
  • Breton AL; Department of Dermatology, Centre Hospitalier, Saint Joseph Saint Luc, Lyon, France.
  • Donzier L; Department of Dermatology, Centre Hospitalier, Saint Joseph Saint Luc, Lyon, France.
  • Tartas S; Department of Oncology, Hospices Civils de Lyon, Oullins-Pierre-Bénite, Lyon, France.
  • Curings P; Department of Plastic Surgery, Centre Hospitalier, Saint Joseph Saint Luc, Lyon, France.
  • Pariset C; Department of Infectious Disease, Centre Hospitalier, Saint Joseph Saint Luc, Lyon, France.
  • Berthoux E; Department of Internal Medicine, Centre Hospitalier, Saint Joseph Saint Luc, Lyon, France.
Lancet ; 403(10446): 2818-2819, 2024 Jun 29.
Article in En | MEDLINE | ID: mdl-38944528
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Purpura Fulminans / Immune Checkpoint Inhibitors / Kidney Neoplasms Limits: Female / Humans / Middle aged Language: En Journal: Lancet Year: 2024 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Purpura Fulminans / Immune Checkpoint Inhibitors / Kidney Neoplasms Limits: Female / Humans / Middle aged Language: En Journal: Lancet Year: 2024 Document type: Article Country of publication: United kingdom